Moderate riskFDA DeviceClass II

Roche Elecsys Anti-TSHR immunoassay recalled for inconsistent test results

Roche Diagnostics has recalled certain lots of the Elecsys Anti-TSHR blood test due to inconsistent results across different laboratory instruments and variations between calibrator batches. These issues could lead to incorrect or delayed thyroid diagnosis and treatment.

From the FDA notice · Read the official notice ↗

What to do

  1. If your doctor ordered an Anti-TSHR (thyroid receptor antibody) test, contact your lab or healthcare provider to confirm which test kit was used
  2. Ask if your results came from one of the recalled lot numbers (840183, 874011, or 840177)
  3. If your lab used a recalled lot, discuss whether your test results should be repeated with a different kit

Is yours affected?

Compare your label or packaging with the recalled product.

Product
The Elecsys Anti-TSHR immunoassay is a three-step competitive immunoassay with streptavidin-coated microparticles and electrochemiluminescence detection. Patient serum sample is incubated with pretreatment reagent PT1 and the reconstituted PT2 containing a pre-formed immunocomplex of solubilized porcine TSH receptor (pTSHR) and biotinylated anti-pTSHR mouse monoclonal antibody.
Sold in
Nationwide
Made for
All ages (under 100 years)

Details

Units affected
1300 cassettes
Illnesses reported
None reported
Manufactured in
9115 Hague Rd, Indianapolis, IN, United States
Classification
Class II
Recall number
Z-1009-2026

In the FDA's words

Description
The Elecsys Anti-TSHR immunoassay is a three-step competitive immunoassay with streptavidin-coated microparticles and electrochemiluminescence detection. Patient serum sample is incubated with pretreatment reagent PT1 and the reconstituted PT2 containing a pre-formed immunocomplex of solubilized porcine TSH receptor (pTSHR) and biotinylated anti-pTSHR mouse monoclonal antibody. Issues identified: 1) Results vary by Instrument Platform; 2) Calibrator Lot-to-Lot Variability. Issues may lead to delayed or incorrect diagnosis, as well as delay of treatment or incorrect treatment. 08496633190 lot 840183 exp. 02/26 08496633190 lot 874011 exp. 10/26 08496609190 lot 840177 exp. 05/26 Distribution: US Nationwide distribution in the states of AZ, CA, FL, GA, IL, IN, ME, MI, MN, NC, NJ, NM, NY, OH, PA, PR, TN, TX, UT, WA, WV. Affected quantity: 1300 cassettes
Hazard
Issues identified: 1) Results vary by Instrument Platform; 2) Calibrator Lot-to-Lot Variability. Issues may lead to delayed or incorrect diagnosis, as well as delay of treatment or incorrect treatment.

Related topics